Amedeo Smart

Free Medical Literature Service

 

Amedeo

Leukemia
  Free Subscription

Articles published in
N Engl J Med
    April 2024
  1. BLAISE D
    CAR as Booster to Launch Allogeneic Transplantation in Refractory Leukemia.
    N Engl J Med. 2024;390:1526-1527.
    >> Share

  2. HU Y, Zhang M, Yang T, Mo Z, et al
    Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD Prophylaxis.
    N Engl J Med. 2024;390:1467-1480.
    >> Share

    December 2023
  3. MUNIR T, Cairns DA, Bloor A, Allsup D, et al
    Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease.
    N Engl J Med. 2023 Dec 10. doi: 10.1056/NEJMoa2310063.
    >> Share

    July 2023
  4. KATER AP, Eichhorst B
    Inhibiting BTK in Chronic Lymphocytic Leukemia.
    N Engl J Med. 2023;389:83-86.
    >> Share

  5. MATO AR, Woyach JA, Brown JR, Ghia P, et al
    Pirtobrutinib after a Covalent BTK Inhibitor in Chronic Lymphocytic Leukemia.
    N Engl J Med. 2023;389:33-44.
    >> Share

    June 2023
  6. CHIESA R, Georgiadis C, Syed F, Zhan H, et al
    Base-Edited CAR7 T Cells for Relapsed T-Cell Acute Lymphoblastic Leukemia.
    N Engl J Med. 2023 Jun 14. doi: 10.1056/NEJMoa2300709.
    >> Share

    May 2023
  7. FORCONI F, Ashton-Key M, Meakin N
    BCL2 Inhibition in Refractory Hairy-Cell Leukemia.
    N Engl J Med. 2023;388:2010-2012.
    >> Share

  8. WOYACH JA, Byrd JC
    Time-Limited Initial Therapy for Young, Fit Patients with CLL.
    N Engl J Med. 2023;388:1812-1813.
    >> Share

  9. EICHHORST B, Niemann CU, Kater AP, Furstenau M, et al
    First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia.
    N Engl J Med. 2023;388:1739-1754.
    >> Share

  10. BROWN JR, Cohen A, Shadman M
    Zanubrutinib in Chronic Lymphocytic Leukemia. Reply.
    N Engl J Med. 2023;388:1720-1721.
    >> Share

  11. LIANG Y, Gale RP
    Zanubrutinib in Chronic Lymphocytic Leukemia.
    N Engl J Med. 2023;388:1720.
    >> Share

  12. BYRD JC, Rothbaum W
    Zanubrutinib in Chronic Lymphocytic Leukemia.
    N Engl J Med. 2023;388:1719-1720.
    >> Share

    April 2023
  13. VAN DER SLUIS IM, de Lorenzo P, Kotecha RS, Attarbaschi A, et al
    Blinatumomab Added to Chemotherapy in Infant Lymphoblastic Leukemia.
    N Engl J Med. 2023;388:1572-1581.
    >> Share

    March 2023
  14. TIACCI E, De Carolis L, Santi A, Falini B, et al
    Venetoclax in Relapsed or Refractory Hairy-Cell Leukemia.
    N Engl J Med. 2023;388:952-954.
    >> Share

    December 2022
  15. BROWN JR, Eichhorst B, Hillmen P, Jurczak W, et al
    Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia.
    N Engl J Med. 2022 Dec 13. doi: 10.1056/NEJMoa2211582.
    >> Share

    June 2022
  16. MONTESINOS P, de Botton S, Dohner H
    Ivosidenib and Azacitidine in IDH1-Mutated AML. Reply.
    N Engl J Med. 2022;386:2536-2537.
    >> Share

  17. GOODMAN AM, Mohyuddin GR, Prasad V
    Ivosidenib and Azacitidine in IDH1-Mutated AML.
    N Engl J Med. 2022;386:2536.
    >> Share

  18. GIL-SIERRA MD, Briceno-Casado MP, Sierra-Sanchez JF
    Ivosidenib and Azacitidine in IDH1-Mutated AML.
    N Engl J Med. 2022;386:2535-2536.
    >> Share

  19. FOA R, Chiaretti S
    Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.
    N Engl J Med. 2022;386:2399-2411.
    >> Share

    May 2022
  20. RODRIGUES GR, Mendonca TM
    Retinal Hemorrhages in Leukemia.
    N Engl J Med. 2022;386:e50.
    >> Share

    April 2022
  21. MONTESINOS P, Recher C, Vives S, Zarzycka E, et al
    Ivosidenib and Azacitidine in IDH1-Mutated Acute Myeloid Leukemia.
    N Engl J Med. 2022;386:1519-1531.
    >> Share

    February 2022
  22. WANG E, Mi X, Thompson MC, Montoya S, et al
    Mechanisms of Resistance to Noncovalent Bruton's Tyrosine Kinase Inhibitors.
    N Engl J Med. 2022;386:735-743.
    >> Share

    January 2022
  23. ROGERS E, Cusnir M
    Gingival Infiltration in Acute Monocytic Leukemia.
    N Engl J Med. 2022;386:79.
    >> Share

    December 2021
  24. GOYAL S, Tisdale J, Schmidt M, Kanter J, et al
    Acute Myeloid Leukemia Case after Gene Therapy for Sickle Cell Disease.
    N Engl J Med. 2021 Dec 12. doi: 10.1056/NEJMoa2109167.
    >> Share

    October 2021
  25. WOO SB, Wu MY, Treister NS, Amrein PC, et al
    Case 33-2021: A 68-Year-Old Man with Painful Mouth Ulcers.
    N Engl J Med. 2021;385:1700-1710.
    >> Share

    September 2021
  26. BARRY D, Schmieder A
    Leukemia Cutis.
    N Engl J Med. 2021;385:1316.
    >> Share

    August 2021
  27. BRUNNER AM, Newcomb RA, Chen YB, Crabbe AM, et al
    Case 26-2021: A 49-Year-Old Man with Relapsed Acute Myeloid Leukemia.
    N Engl J Med. 2021;385:834-843.
    >> Share

  28. BEATTY CJ, Ghareeb ER
    Neutrophilic Eccrine Hidradenitis.
    N Engl J Med. 2021;385:e19.
    >> Share

    May 2021
  29. MARKEWITZ RDH, Dargvainiene J
    Mitotic and Apoptotic Figures on a Peripheral-Blood Smear.
    N Engl J Med. 2021;384:1942.
    >> Share

  30. TIACCI E, De Carolis L, Simonetti E, Capponi M, et al
    Vemurafenib plus Rituximab in Refractory or Relapsed Hairy-Cell Leukemia.
    N Engl J Med. 2021;384:1810-1823.
    >> Share

  31. MEJIA BURITICA L, Karduss Urueta AJ
    Pulmonary Mucormycosis.
    N Engl J Med. 2021;384:e69.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016